S. V. Dumova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
S. V. Dumova has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Olga L. Chugunova
Pirogov Russian National Research Medical University
11 shared publications - Petr V. Shumilov
Pirogov Russian National Research Medical University
9 shared publications - H. A. Sarkisyan
Pirogov Russian National Research Medical University
8 shared publications - I. V. Zhuravleva
Pirogov Russian National Research Medical University
4 shared publications - Nataliya A. Semenova
Research Centre for Medical Genetics, 115522 Moscow, Russia
4 shared publications - A. P. Khokhlova
Pirogov Russian National Research Medical University
2 shared publications
Latest Publications
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 23 (4)
Early manifestations of D-2-hydroxyglutaric aciduria type II
D-2-hydroxyglutaric aciduria type II (ICD-10 code E72.8: Other specified disorders of amino-acid metabolism, ОMIM #613657) is a rare neurometabolic disorder associated with a pathogenic mutation in the IDH2 gene, which encodes a mitochondrial enzyme called isocitrate dehydrogenase 2. The pathogenesis of the disease is based on the accumulation of neurotoxic and cytotoxic 2-hydroxyglutarate in the body fluids, leading to the development of characteristic clinical manifestations. These include neurological disorders and eye conditions, hypotonia, neurodevelopmental delay, seizures, and cardiomyopathy. D-2-hydroxyglutaric aciduria type II has not been sufficiently studied. Despite the introduction of many metabolic disorders in expanded newborn screening, including glutamic acidemias, which are similar in name and course, this disease is still diagnosed only with the help of special biochemical and molecular genetic tests. This article presents early manifestations, developmental characteristics, neuropsychological and infectious status in a child with D-2-hydroxyglutaric aciduria. Key words: D-2-hydroxyglutaric aciduria type II, D-2-hydroxyglutarate, IDH2 gene, epilepsy, cardiomyopathy, infectious process, developmental delay, hypoxic-ischemic encephalopathy, floppy infant syndrome
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 23 (4)
Early manifestations of D-2-hydroxyglutaric aciduria type II
D-2-hydroxyglutaric aciduria type II (ICD-10 code E72.8: Other specified disorders of amino-acid metabolism, ОMIM #613657) is a rare neurometabolic disorder associated with a pathogenic mutation in the IDH2 gene, which encodes a mitochondrial enzyme called isocitrate dehydrogenase 2. The pathogenesis of the disease is based on the accumulation of neurotoxic and cytotoxic 2-hydroxyglutarate in the body fluids, leading to the development of characteristic clinical manifestations. These include neurological disorders and eye conditions, hypotonia, neurodevelopmental delay, seizures, and cardiomyopathy. D-2-hydroxyglutaric aciduria type II has not been sufficiently studied. Despite the introduction of many metabolic disorders in expanded newborn screening, including glutamic acidemias, which are similar in name and course, this disease is still diagnosed only with the help of special biochemical and molecular genetic tests. This article presents early manifestations, developmental characteristics, neuropsychological and infectious status in a child with D-2-hydroxyglutaric aciduria. Key words: D-2-hydroxyglutaric aciduria type II, D-2-hydroxyglutarate, IDH2 gene, epilepsy, cardiomyopathy, infectious process, developmental delay, hypoxic-ischemic encephalopathy, floppy infant syndrome
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 23 (4)
2-hydroxyglutaric aciduria in the practice of neonatologists and pediatricians: possibilities for early diagnosis and treatment
2-hydroxyglutaric aciduria (ICD-10 code E72.8: Other specified disorders of amino-acid metabolism) is a group of rare metabolic disorders resulting from the accumulation of α-ketoglutarate derivatives in mitochondria: D- and L-enantiomers of 2-hydroxyglutaric acid. This pathology is caused by a wide range of mutations in the genes of mitochondrial enzymes, which explains the existence of several subtypes of the disease in the described group. Over the 45 years since the first mention of 2-hydroxyglutaric aciduria, nearly 500 cases have been reported worldwide. 2-hydroxyglutaric aciduria leads to multisystemic disorders, primarily neurological, severe disability, or death, which determines the importance of early diagnosis. The disease is not included in neonatal screening, but certain similarities between its clinical and laboratory manifestations and various acidemias and other metabolic disorders, as well as their severe consequences and outcomes, necessitate further study and systematization of knowledge about this pathology. This article describes current approaches to the diagnosis and treatment of 2-hydroxyglutaric aciduria in newborns and young children. Key words: inherited metabolic disorders, aciduria, 2-hydroxyglutaric acid, 2-hydroxyglutaric aciduria, D-2-hydroxyglutaric aciduria types I and II, L-2-hydroxyglutaric aciduria
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 23 (4)
2-hydroxyglutaric aciduria in the practice of neonatologists and pediatricians: possibilities for early diagnosis and treatment
2-hydroxyglutaric aciduria (ICD-10 code E72.8: Other specified disorders of amino-acid metabolism) is a group of rare metabolic disorders resulting from the accumulation of α-ketoglutarate derivatives in mitochondria: D- and L-enantiomers of 2-hydroxyglutaric acid. This pathology is caused by a wide range of mutations in the genes of mitochondrial enzymes, which explains the existence of several subtypes of the disease in the described group. Over the 45 years since the first mention of 2-hydroxyglutaric aciduria, nearly 500 cases have been reported worldwide. 2-hydroxyglutaric aciduria leads to multisystemic disorders, primarily neurological, severe disability, or death, which determines the importance of early diagnosis. The disease is not included in neonatal screening, but certain similarities between its clinical and laboratory manifestations and various acidemias and other metabolic disorders, as well as their severe consequences and outcomes, necessitate further study and systematization of knowledge about this pathology. This article describes current approaches to the diagnosis and treatment of 2-hydroxyglutaric aciduria in newborns and young children. Key words: inherited metabolic disorders, aciduria, 2-hydroxyglutaric acid, 2-hydroxyglutaric aciduria, D-2-hydroxyglutaric aciduria types I and II, L-2-hydroxyglutaric aciduria
- 26 December 2024
- Published by Open Systems Publications in Лечащий врач
- No. 12(27)
Genetic aspects of nonimmune hydrops fetalis
Background. Nonimmune hydrops fetalis is a heterogeneous disorder characterized by generalized hyperhydration caused by extracellular accumulation of fluid in the tissues and serous cavities of the fetus, in the absence of signs of immune sensitization. The prevalence of nonimmune hydrops fetalis, according to various data, ranges from 0.05 to 0.5%, or about 1:4000 live births. Nonimmune hydrops fetalis is based on more than 150 different nosologies. A significant proportion of all the causes leading to nonimmune hydrops fetalis are disorders in the genetic material of the fetus: chromosomal abnormalities, genetic and genomic disorders, RAS pathologies. Most often, nonimmune hydrops fetalis accompanies mutations with a change in the number of chromosomes, such as Down syndrome, Edwards and Turner. In addition, perinatal viral infections, malformations of the lymphatic, cardiovascular, musculoskeletal and endocrine systems, lysosomal accumulation diseases and other pathologies play an important role in the development of nonimmune hydrops fetalis. The improvement of prenatal diagnostic methods, especially cytogenetic research methods, made it possible to identify the genetic cause of nonimmune hydrops fetalis in a large number of cases, while reducing the group of idiopathic nonimmune hydrops fetalis. Modern ultrasound screening methods make it possible to suspect the presence of a genetic anomaly and associated nonimmune hydrops fetalis already in the first trimester of pregnancy. The identification of the etiology of nonimmune hydrops fetalis, in turn, is a determining factor in choosing the tactics of pregnancy management, determining the possibilities and prospects of intrauterine treatment. Targeted therapy is an effective therapy for genetically determined nonimmune hydrops fetalis, which is a promising direction in the treatment of certain pathologies and is actively developing today. The development of genetically engineered therapy, in addition to correcting the underlying pathology, can lead to a decrease in mortality in nonimmune hydrops fetalis, which currently reaches 90%. Conclusion. This work reflects the etiological structure of nonimmune hydrops fetalis with an emphasis on genetic disorders, and also notes the diagnostic, therapeutic and prognostic features of pregnancy management with nonimmune hydrops fetalis.
- 26 December 2024
- Published by Open Systems Publications in Лечащий врач
- No. 12(27)
Genetic aspects of nonimmune hydrops fetalis
Background. Nonimmune hydrops fetalis is a heterogeneous disorder characterized by generalized hyperhydration caused by extracellular accumulation of fluid in the tissues and serous cavities of the fetus, in the absence of signs of immune sensitization. The prevalence of nonimmune hydrops fetalis, according to various data, ranges from 0.05 to 0.5%, or about 1:4000 live births. Nonimmune hydrops fetalis is based on more than 150 different nosologies. A significant proportion of all the causes leading to nonimmune hydrops fetalis are disorders in the genetic material of the fetus: chromosomal abnormalities, genetic and genomic disorders, RAS pathologies. Most often, nonimmune hydrops fetalis accompanies mutations with a change in the number of chromosomes, such as Down syndrome, Edwards and Turner. In addition, perinatal viral infections, malformations of the lymphatic, cardiovascular, musculoskeletal and endocrine systems, lysosomal accumulation diseases and other pathologies play an important role in the development of nonimmune hydrops fetalis. The improvement of prenatal diagnostic methods, especially cytogenetic research methods, made it possible to identify the genetic cause of nonimmune hydrops fetalis in a large number of cases, while reducing the group of idiopathic nonimmune hydrops fetalis. Modern ultrasound screening methods make it possible to suspect the presence of a genetic anomaly and associated nonimmune hydrops fetalis already in the first trimester of pregnancy. The identification of the etiology of nonimmune hydrops fetalis, in turn, is a determining factor in choosing the tactics of pregnancy management, determining the possibilities and prospects of intrauterine treatment. Targeted therapy is an effective therapy for genetically determined nonimmune hydrops fetalis, which is a promising direction in the treatment of certain pathologies and is actively developing today. The development of genetically engineered therapy, in addition to correcting the underlying pathology, can lead to a decrease in mortality in nonimmune hydrops fetalis, which currently reaches 90%. Conclusion. This work reflects the etiological structure of nonimmune hydrops fetalis with an emphasis on genetic disorders, and also notes the diagnostic, therapeutic and prognostic features of pregnancy management with nonimmune hydrops fetalis.
- 10 December 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (6)
Variability of 2q37 deletion syndrome features as exemplified by several clinical case reports
2q37 deletion syndrome is characterized by terminal deletions of the long arm of chromosome 2 and a variable clinical picture that includes type E brachydactyly, obesity, delayed motor and psychomotor development, congenital malformations of internal organs and the facial phenotype particular qualities. Authors present the two clinical case reports of patients with 2q37 deletions demonstrating different clinical manifestations. Proband 1 complained exclusively of brachydactyly while proband 2 had almost the full spectrum of clinical symptoms characterizing the syndrome. The Face2Gene AI-Powered Diagnosis & Care Management Tool suggested the correct diagnosis in both cases based on the features of the facial phenotype that in its turn became the key factors in choosing the tactics for further molecular genetic diagnostics. Conclusion: careful collection of anamnesis data, description of the facial phenotype and the use of artificial intelligence-based tools can become the key factors in choosing the tactics for the molecular genetic diagnostics available for practitioners of various specialties.
- 10 December 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (6)
Variability of 2q37 deletion syndrome features as exemplified by several clinical case reports
2q37 deletion syndrome is characterized by terminal deletions of the long arm of chromosome 2 and a variable clinical picture that includes type E brachydactyly, obesity, delayed motor and psychomotor development, congenital malformations of internal organs and the facial phenotype particular qualities. Authors present the two clinical case reports of patients with 2q37 deletions demonstrating different clinical manifestations. Proband 1 complained exclusively of brachydactyly while proband 2 had almost the full spectrum of clinical symptoms characterizing the syndrome. The Face2Gene AI-Powered Diagnosis & Care Management Tool suggested the correct diagnosis in both cases based on the features of the facial phenotype that in its turn became the key factors in choosing the tactics for further molecular genetic diagnostics. Conclusion: careful collection of anamnesis data, description of the facial phenotype and the use of artificial intelligence-based tools can become the key factors in choosing the tactics for the molecular genetic diagnostics available for practitioners of various specialties.
- 11 July 2024
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 69 (3) , 19-28
Peculiarities of development and lesions of the central nervous system in late preterm newborns
The last weeks of pregnancy are a critical period of intrauterine development of the central nervous system. In late preterm infants born at gestational age 340/7 — 366/7 weeks, the maturation of the central nervous system continues postnatally, which determines its high vulnerability to various pathologic effects. Morphofunctional immaturity and frequent complications of the neonatal period increase the likelihood of early brain lesions leading to further disorders of neuropsychiatric development. Even in the absence of clinically significant neurological abnormalities in the neonatal period, late preterm neonates have a risk of social-adaptive, behavioral, motor and cognitive impairments in later life. Predicting the outcome of central nervous system lesions in late preterm neonates is possible with the help of neuroimaging methods, as well as with the use of specialized tools to assess various areas of psychomotor development. Modern approaches to prevent neurological complications include prevention and treatment of hypoxia, hypoglycemia, hyperbilirubinemia, infections, provision of adequate nutritional support and adherence to vaccination in late preterm neonates.
- 11 July 2024
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 69 (3) , 19-28
Peculiarities of development and lesions of the central nervous system in late preterm newborns
The last weeks of pregnancy are a critical period of intrauterine development of the central nervous system. In late preterm infants born at gestational age 340/7 — 366/7 weeks, the maturation of the central nervous system continues postnatally, which determines its high vulnerability to various pathologic effects. Morphofunctional immaturity and frequent complications of the neonatal period increase the likelihood of early brain lesions leading to further disorders of neuropsychiatric development. Even in the absence of clinically significant neurological abnormalities in the neonatal period, late preterm neonates have a risk of social-adaptive, behavioral, motor and cognitive impairments in later life. Predicting the outcome of central nervous system lesions in late preterm neonates is possible with the help of neuroimaging methods, as well as with the use of specialized tools to assess various areas of psychomotor development. Modern approaches to prevent neurological complications include prevention and treatment of hypoxia, hypoglycemia, hyperbilirubinemia, infections, provision of adequate nutritional support and adherence to vaccination in late preterm neonates.
- Open Access
- 24 June 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (2) , 39-44
A case of early neonatal sepsis caused by Streptococcus pneumoniae
The article presents a case of early neonatal sepsis in a premature neonate caused by Streptococcus pneumoniae with the development of purulent meningitis, describes the diagnostic possibilities and features of treatment, as well as the outcome of this condition in the child. In the presented case the rapid increase of symptoms of meningo-encephalitis, slow sanation of liquor, despite the adequacy of the conducted therapy, attracts attention.
- 24 June 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (2) , 39-44
Open AccessA case of early neonatal sepsis caused by Streptococcus pneumoniae
The article presents a case of early neonatal sepsis in a premature neonate caused by Streptococcus pneumoniae with the development of purulent meningitis, describes the diagnostic possibilities and features of treatment, as well as the outcome of this condition in the child. In the presented case the rapid increase of symptoms of meningo-encephalitis, slow sanation of liquor, despite the adequacy of the conducted therapy, attracts attention.
- Open Access
- 23 March 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (1) , 35-43
Non-immune hydrops fetalis: etiology, pathogenesis, features of diagnosis and treatment in the fetus and newborn
Non-immune hydrops fetalis is a polyetiological disease characterized by high perinatal mortality. The development of non-immune fetal hydrops is associated with diseases of the cardiovascular and lymphatic systems, genetic and chromosomal diseases, infectious agents and many other reasons. In this regard, there is no single approach to the treatment of this extremely dangerous pathological condition, which requires the joint work of specialists from different specialties: obstetricians-gynecologists, neonatologists, cardiologists, surgeons, hematologists and geneticists. This article provides a review of current literature data on the etiology, pathogenesis, clinical manifestations, treatment and outcomes of non-immune hydrops fetalis.
- 23 March 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (1) , 35-43
Open AccessNon-immune hydrops fetalis: etiology, pathogenesis, features of diagnosis and treatment in the fetus and newborn
Non-immune hydrops fetalis is a polyetiological disease characterized by high perinatal mortality. The development of non-immune fetal hydrops is associated with diseases of the cardiovascular and lymphatic systems, genetic and chromosomal diseases, infectious agents and many other reasons. In this regard, there is no single approach to the treatment of this extremely dangerous pathological condition, which requires the joint work of specialists from different specialties: obstetricians-gynecologists, neonatologists, cardiologists, surgeons, hematologists and geneticists. This article provides a review of current literature data on the etiology, pathogenesis, clinical manifestations, treatment and outcomes of non-immune hydrops fetalis.
- 15 December 2023
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 102 (6)
Hereditary forms of prion disease in pediatric practice: bibliographic review and series of clinical cases
- 15 December 2023
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 102 (6)
Hereditary forms of prion disease in pediatric practice: bibliographic review and series of clinical cases
- 6 September 2023
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 68 (4) , 14-23
Current approaches to respiratory pathology in late preterm infants
Late preterm babies are those born between 340/7 and 366/7 weeks of gestation, constituting the largest subgroup of preterm infants. Despite the relative morphofunctional maturity, these children remain at a high risk of damage to various organs and systems, and there is also a high mortality rate. One of the top places in the structure of morbidity in late preterm is occupied by respiratory disorders. Quite often there is transient tachypnea, respiratory distress syndrome of the newborn, pulmonary hypertension, and congenital pneumonia. Currently, there are various approaches to prevention, treatment, and diagnosis of respiratory disorders in late preterm children. Until now, the issue of the advisability of prenatal prevention of respiratory distress syndrome with corticosteroids after the 34th week of gestation has not been resolved. Non-invasive methods of respiratory support are more popular along with minimally invasive administration of surfactant preparations when indicated. The trend towards an annual increase in late preterm births determines the need to improve the methods of their nursing. The control over respiratory disorders and hypoxia is crucial in the prevention of adverse outcomes in late preterm children.
- 6 September 2023
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 68 (4) , 14-23
Current approaches to respiratory pathology in late preterm infants
Late preterm babies are those born between 340/7 and 366/7 weeks of gestation, constituting the largest subgroup of preterm infants. Despite the relative morphofunctional maturity, these children remain at a high risk of damage to various organs and systems, and there is also a high mortality rate. One of the top places in the structure of morbidity in late preterm is occupied by respiratory disorders. Quite often there is transient tachypnea, respiratory distress syndrome of the newborn, pulmonary hypertension, and congenital pneumonia. Currently, there are various approaches to prevention, treatment, and diagnosis of respiratory disorders in late preterm children. Until now, the issue of the advisability of prenatal prevention of respiratory distress syndrome with corticosteroids after the 34th week of gestation has not been resolved. Non-invasive methods of respiratory support are more popular along with minimally invasive administration of surfactant preparations when indicated. The trend towards an annual increase in late preterm births determines the need to improve the methods of their nursing. The control over respiratory disorders and hypoxia is crucial in the prevention of adverse outcomes in late preterm children.
- 17 February 2023
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 102 (1)
ANATOMICAL AND PHYSIOLOGICAL FEATURES OF LATE PREMATURE INFANTS LEADING TO THE FORMATION OF VARIOUS PATHOLOGICAL PROCESSES
Late premature infants are those who were born at GA of 34 to 36 weeks. Despite the GA, the high weight and growth rates, this group of newborns is much more likely than full-term children to experience disruptions in neonatal adaptation, damage to the respiratory system, CNS, the development of infectious complications, asphyxia, hypothermia, hypoglycemia, hyperbilirubinemia. All of these lead to an increase in morbidity, mortality and disability not only in the first months of life, but also in the future, therefore late premature infants cannot be treated as/kind of “almost full-term.” This bibliographical review represents the data on the features of the development of various pathological processes, outcomes and treatment options in late preterm infants.
- 17 February 2023
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 102 (1)
ANATOMICAL AND PHYSIOLOGICAL FEATURES OF LATE PREMATURE INFANTS LEADING TO THE FORMATION OF VARIOUS PATHOLOGICAL PROCESSES
Late premature infants are those who were born at GA of 34 to 36 weeks. Despite the GA, the high weight and growth rates, this group of newborns is much more likely than full-term children to experience disruptions in neonatal adaptation, damage to the respiratory system, CNS, the development of infectious complications, asphyxia, hypothermia, hypoglycemia, hyperbilirubinemia. All of these lead to an increase in morbidity, mortality and disability not only in the first months of life, but also in the future, therefore late premature infants cannot be treated as/kind of “almost full-term.” This bibliographical review represents the data on the features of the development of various pathological processes, outcomes and treatment options in late preterm infants.